RaySearch Laboratories AB (STO:RAY.B), a provider of software for radiation therapy, announced on Friday that it has secured an order worth DKK10.5m (approximately SEK15.4m) from Odense University Hospital, part of the South Denmark Region, for its RayStation treatment planning system.
Odense University Hospital's radiotherapy centre, a leader in automated treatment planning, aims to further expand automation across the entire planning process, from initial assessments to finalised treatment plans. RayStation was selected following an extensive market evaluation focused on supporting continued innovation in automation.
RayStation integrates both machine learning and traditional planning algorithms. Its upcoming version will feature a new auto-optimisation algorithm, currently under development in collaboration with Memorial Sloan Kettering Cancer Center.
Most of the revenue from the order is expected to be recognized in the first quarter of 2025. The agreement excludes a service contract and remains subject to regulatory clearance in certain markets.
(USD1.00 = DKK6.57)
enGene reports 62% six-month complete response rate for detalimogene in LEGEND trial
QIAGEN launches QIAsymphony Connect and showcases new precision oncology advances at AMP 2025
Innate Pharma cleared by FDA to launch TELLOMAK 3 Phase 3 trial of lacutamab in CTCL
Exact Sciences secures US exclusive license to Freenome's blood-based colorectal cancer tests
Evinova China and Harbour BioMed form AI partnership to accelerate biologics development
OncoHost receives Proteomics Innovation of the Year in BioTech Breakthrough Awards